Observational Study on the Occurrence of Hepatosplenic T-cell Lymphoma in Patients of Netherlands

Centocor Ortho Biotech

Status: Completed

Conditions: Hepatosplenic T-cell Lymphoma

Treatments: Other: No intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT00731536

C0168Z06 (Other Identifier)

CR015394

Details and patient eligibility

About

The purpose of this study is to examine reports of the cancer called hepatosplenic T-cell lymphoma (HSTCL) in the Dutch National Database of Pathology (Pathologisch-Anatomisch Landelijk Geautomatiseerd Archief or PALGA) during the years 1995 to 2008.

Full description

This is a observational, retrospective (a study in which the participants are identified and then followed backward in time, for the outcome of the study) study. In this study review of all reports of possible cases of hepatosplenic T-cell lymphoma (HSTCL) that were identified within the PALGA database of pathology results for The Netherlands from 1995 to 2008. All patients whose information is contained within the PALGA database were prescribed treatments by a physician on the basis of usual clinical practice or may have received other treatments, including experimental drugs, while participating in an interventional clinical study. The identified data on each of the patients with reports of HSTCL will be collected from the pathologist(s) who prepared the report and from the physician(s) who treated the patient at the time of diagnosis.

Enrollment: 15 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with HSTCL in the Dutch National Database of Pathology (Pathologisch-Anatomisch Landelijk Geautomatiseerd Archief) database during the years 1995 to 2008

Exclusion criteria

• Patients who are not diagnosed with HSTCL

Trial design

15 participants in 1 patient group

Patients with Hepatosplenic T-cell Lymphoma (HSTCL)

Treatment:

Other: No intervention